Cargando…
Recent advances in the management of malignant pheochromocytoma and paraganglioma: focus on tyrosine kinase and hypoxia-inducible factor inhibitors
Inactivating mutations of the succinate dehydrogenase subunit B ( SDHB) gene and the subsequent stabilization and activation of the hypoxia-inducible factor 2-alpha (HIF2α) unit are recognized hallmarks associated with the development of metastatic pheochromocytomas and paragangliomas (MPPG). Despit...
Autores principales: | Toledo, Rodrigo, Jimenez, Camilo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069727/ https://www.ncbi.nlm.nih.gov/pubmed/30109021 http://dx.doi.org/10.12688/f1000research.13995.1 |
Ejemplares similares
-
Tyrosine kinase receptors as molecular targets In pheochromocytomas and paragangliomas
por: Cassol, Clarissa A., et al.
Publicado: (2014) -
Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer
por: Jimenez, Camilo
Publicado: (2018) -
Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma
por: Hensen, Erik F., et al.
Publicado: (2010) -
Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma
por: Kluckova, Katarina, et al.
Publicado: (2018) -
Endocrine and Neuroendocrine Tumors Special Issue—Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work?
por: Jimenez, Camilo, et al.
Publicado: (2022)